These products tend to have downward pressure on price over time, and we're obviously seeing that. Lifetime Benefits vs Cost Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, was approved for weight management in 2023, while semaglutide, a GLP-1 receptor agonist, was approved 2 years earlier
This off-label practice extends medication supply during shortages and improves adherence for sensitive patients
A TikTok user shared that she had headaches, dizzying nausea, and fatigue from using Ozempic, but injecting the medication in the upper arm rather than the stomach might limit these side effects
These studies attempt to replicate prior findings, identify adverse effects and determine the efficacy during prolonged use
This is the first report with a higher prescription rate for AOM tirzepatide compared to AOM semaglutide (sold as Wegovy)
Goal: Stimulate a short pulse of pituitary growth hormone via the ghrelin (GHS-R1a) receptor